Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rune Wiseth

Showing results (81-90 of 103) with videos related to

Pageof 11
Sort By:
International Journal of Cardiology. Cardiovascular Risk and Prevention|June 12, 2025
Circulating protein biomarkers and their association with vulnerable plaque characteristics - a PROSPECT II substudyTania Sharma, Akiko Maehara, Michael Maeng, et al.
Open Heart|November 2, 2019
Rationale for the ASSAIL-MI-trial: a randomised controlled trial designed to assess the effect of tocilizumab on myocardial salvage in patients with acute ST-elevation myocardial infarction (STEMI)Anne Kristine Anstensrud, Sindre Woxholt, Kapil Sharma, et al.
Circulation. Cardiovascular Interventions|September 25, 2024
Impact of Lipidic Plaque on In-Stent and Stent Edge-Related Events After PCI in Myocardial Infarction: A PROSPECT II SubstudyLars Kjøller-Hansen, Akiko Maehara, Henning Kelbæk, et al.
Journal of the American College of Cardiology|October 18, 2020
Percutaneous Coronary Intervention for Vulnerable Coronary Atherosclerotic PlaqueGregg W Stone, Akiko Maehara, Ziad A Ali, et al.
Open Heart|August 17, 2023
Cytokine pattern in patients with ST-elevation myocardial infarction treated with the interleukin-6 receptor antagonist tocilizumabSindre Woxholt, T Ueland, Pål Aukrust, et al.
Circulation|June 23, 2025
Nonculprit Vulnerable Plaques and Prognosis in Myocardial Infarction With Versus Without ST-Segment Elevation: A PROSPECT II SubstudyPernille G Thrane, Michael Maeng, Akiko Maehara, et al.
American Heart Journal|December 12, 2018
BEtablocker Treatment After acute Myocardial Infarction in revascularized patients without reduced left ventricular ejection fraction (BETAMI): Rationale and design of a prospective, randomized, open, blinded end point studyJohn Munkhaugen, Vidar Ruddox, Sigrun Halvorsen, et al.
Journal of the American College of Cardiology|April 16, 2021
Randomized Trial of Interleukin-6 Receptor Inhibition in Patients With Acute ST-Segment Elevation Myocardial InfarctionKaspar Broch, Anne Kristine Anstensrud, Sindre Woxholt, et al.
Circulation|October 25, 2006
Randomized study on simple versus complex stenting of coronary artery bifurcation lesions: the Nordic bifurcation studyTerje K Steigen, Michael Maeng, Rune Wiseth, et al.
Circulation|December 16, 2022
Coronary Artery Lesion Lipid Content and Plaque Burden in Diabetic and Nondiabetic Patients: PROSPECT IIChristine Gyldenkerne, Michael Maeng, Lars Kjøller-Hansen, et al.
Pageof 11

Showing results (81-90 of 103) with videos related to

Sort By:
Pageof 11
International Journal of Cardiology. Cardiovascular Risk and Prevention|June 12, 2025
Circulating protein biomarkers and their association with vulnerable plaque characteristics - a PROSPECT II substudyTania Sharma, Akiko Maehara, Michael Maeng, et al.
Open Heart|November 2, 2019
Rationale for the ASSAIL-MI-trial: a randomised controlled trial designed to assess the effect of tocilizumab on myocardial salvage in patients with acute ST-elevation myocardial infarction (STEMI)Anne Kristine Anstensrud, Sindre Woxholt, Kapil Sharma, et al.
Circulation. Cardiovascular Interventions|September 25, 2024
Impact of Lipidic Plaque on In-Stent and Stent Edge-Related Events After PCI in Myocardial Infarction: A PROSPECT II SubstudyLars Kjøller-Hansen, Akiko Maehara, Henning Kelbæk, et al.
Journal of the American College of Cardiology|October 18, 2020
Percutaneous Coronary Intervention for Vulnerable Coronary Atherosclerotic PlaqueGregg W Stone, Akiko Maehara, Ziad A Ali, et al.
Open Heart|August 17, 2023
Cytokine pattern in patients with ST-elevation myocardial infarction treated with the interleukin-6 receptor antagonist tocilizumabSindre Woxholt, T Ueland, Pål Aukrust, et al.
Circulation|June 23, 2025
Nonculprit Vulnerable Plaques and Prognosis in Myocardial Infarction With Versus Without ST-Segment Elevation: A PROSPECT II SubstudyPernille G Thrane, Michael Maeng, Akiko Maehara, et al.
American Heart Journal|December 12, 2018
BEtablocker Treatment After acute Myocardial Infarction in revascularized patients without reduced left ventricular ejection fraction (BETAMI): Rationale and design of a prospective, randomized, open, blinded end point studyJohn Munkhaugen, Vidar Ruddox, Sigrun Halvorsen, et al.
Journal of the American College of Cardiology|April 16, 2021
Randomized Trial of Interleukin-6 Receptor Inhibition in Patients With Acute ST-Segment Elevation Myocardial InfarctionKaspar Broch, Anne Kristine Anstensrud, Sindre Woxholt, et al.
Circulation|October 25, 2006
Randomized study on simple versus complex stenting of coronary artery bifurcation lesions: the Nordic bifurcation studyTerje K Steigen, Michael Maeng, Rune Wiseth, et al.
Circulation|December 16, 2022
Coronary Artery Lesion Lipid Content and Plaque Burden in Diabetic and Nondiabetic Patients: PROSPECT IIChristine Gyldenkerne, Michael Maeng, Lars Kjøller-Hansen, et al.
Pageof 11